Indeed, although the CSF tau profile in CJD patients usually combines excessively high t-tau with relatively low p-tau concentrations [21, 57, 67, 68], we and other authors have clearly shown that CSF p-tau levels can be significantly raised in prion disease too, owing, once again, to the heterogeneity of the disease. This evidence concerns the gene MAPT and prion disease.